Aera Therapeutics

Unlocking the potential of genetic medicines.

Boston, United States · Founded 2021 · $193.0M raised

Headquarters
Boston
Employees
51–200
Founded
2021
Business Model
B2B
Website
aeratx.com
Total Funding
$193.0M
Last Round
$193.0M Series AFeb 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aera Therapeutics is developing next-generation genetic medicines by solving the delivery challenge. Their proprietary platforms — targeted lipid nanoparticles (tLNPs), antibody oligonucleotide conjugates (AOCs), and protein nanoparticles (PNPs) — enable precise delivery of genetic therapies across tissues and disease areas to benefit more patients.

Summary

Aera Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $193.0M in total across 1 round, most recently a $193.0M Series A round in Feb 2023. Investors include ARCH Venture Partners, GV and Lux Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2023
$193.0M

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aera-therapeutics"><img src="https://indexed.vc/api/badge/company/aera-therapeutics" alt="Aera Therapeutics on Indexed.vc" width="260" height="76" /></a>